Medical industry performance shows up in how countries allocate spending across pharmaceuticals, devices, and digital health, from OECD systems to the U.S. It also reflects patient-safety and quality pressures, including preventable complications and adverse events, alongside waste and administrative complexity. As you read, you’ll see how telehealth, remote monitoring, and automation are reshaping delivery—plus why recalls and ransomware-linked breaches matter for trust. The page also grounds disease burden with survival differences in major cancers.
Key Takeaways
- $5,807 per capita global healthcare spending in 2022
- $399.3 billion forecast medical device market size in 2025 in the United States (spending)
- $1,687.5 billion forecast global pharmaceutical market size in 2032
- 27% of total health expenditures in OECD countries spent on pharmaceutical products in 2022
- $172 billion estimated U.S. waste in healthcare spending annually (including overtreatment and administrative complexity)
- 10.6% of healthcare spending in the U.S. attributed to prescription drugs in 2022 (share of NHE)
- 34% relative reduction in surgical site infections with surgical antibiotic prophylaxis when administered within recommended timing (systematic review)
- 22% relative reduction in mortality with inpatient glycemic control strategies (systematic review)
- Telehealth use in the U.S. rose from 11% of visits in 2019 to 46% in 2020 during the COVID-19 peak (private claims analysis)
- 1,000+ reported medical device recalls in 2022 in the U.S. (FDA recall database count)
- 24.4% increase in HIPAA breaches from 2020 to 2021 (OCR breach report trend)
- 1.2 million annual adverse events reported under Medicare in 2019 (AHRQ estimate)
- 27% of healthcare organizations planned to increase AI/ML investment in 2024 (survey)
- 84% of healthcare providers expect to use more automation in operations by 2025 (survey)
- COVID-19 drove a 38% increase in telehealth utilization in the U.S. from 2019 to 2021 (claims-based analysis)
Healthcare spending and innovation are accelerating, while waste, infections, and data breaches still drive major risks.
Related reading
01 · Category
Market Size10 stats
01
$5,807per capita global healthcare spending in 2022
02
$399.3 billion forecast medical device market size in 2025 in the United States (spending)
03
$1,687.5 billion forecast global pharmaceutical market size in 2032
04
$110.1 billion projected global digital health market size in 2024
05
$1.47 trillion global hospital market size in 2024
06
$37.6 billion global outpatient services market size in 2024
07
$51.2 billion expected global healthcare cybersecurity market size in 2028
08
$7.1 billion global medical imaging market size in 2023
09
5.5% of U.S. adults reported being uninsured in 2023 (U.S. Census Bureau ACS)
10
$536.7 billion U.S. hospital construction spending forecast for 2024–2030 (Dodge Construction Network forecast)
Interpretation
Market Size Interpretation
The market size data shows medical spending and healthcare-related industries are scaling quickly, with global healthcare spending reaching $5,807 per person in 2022 and major sectors projected to grow to $1,687.5 billion in pharmaceuticals by 2032 and $110.1 billion in digital health by 2024.
02 · Category
Industry Trends8 stats
01
27% of healthcare organizations planned to increase AI/ML investment in 2024 (survey)
02
84% of healthcare providers expect to use more automation in operations by 2025 (survey)
03
COVID-19 drove a 38% increase in telehealth utilization in the U.S. from 2019 to 2021 (claims-based analysis)
04
In 2023, 68% of healthcare data breaches involved ransomware (industry analysis)
05
In 2024, cloud-native applications are used by 46% of healthcare organizations (survey)
06
90% of imaging departments plan to adopt AI-assisted imaging by 2026 (survey)
07
45% of health systems planned to increase their use of AI/analytics in 2024 (survey of U.S. health organizations, peer publication)
08
52% of healthcare organizations reported implementing or piloting generative AI as of 2024 (global survey, vendor-independent analysis)
Interpretation
Industry Trends Interpretation
Across industry trends in healthcare, organizations are clearly accelerating adoption of advanced digital tools, with 27% planning higher AI and 2024 investments and 84% expecting more operational automation by 2025.
03 · Category
Cost Analysis10 stats
01
27% of total health expenditures in OECD countries spent on pharmaceutical products in 2022
02
$172 billion estimated U.S. waste in healthcare spending annually (including overtreatment and administrative complexity)
03
10.6% of healthcare spending in the U.S. attributed to prescription drugs in 2022 (share of NHE)
04
4.1% of healthcare spending spent on administrative costs in the U.S. (share estimate)
05
$46.1 billion estimated cost of medication errors in U.S. hospitals per year (study estimate)
06
3.2% of inpatient costs attributed to adverse drug events in a hospital cost analysis (U.S.)
07
$1.5 million median cost of a major data breach in healthcare (global average, IBM report)
08
27% of total health expenditures in OECD countries were spent on pharmaceutical products in 2022
09
22.6% of total health expenditures in OECD countries were spent on pharmaceutical products in 2010
10
25.5% of total health expenditures in OECD countries were spent on pharmaceutical products in 2015
Interpretation
Cost Analysis Interpretation
Cost analysis shows that drug-related spending is a major pressure point, with 27% of total OECD health expenditures going to pharmaceutical products in 2022 and the United States spending 10.6% of healthcare expenditures on prescription drugs in 2022, while avoidable inefficiencies add further burden through $172 billion in estimated waste and $46.1 billion in medication errors each year.
More related reading
report visual · Projection
Pharmaceuticals’ share of OECD health spending rose over time
From 2010 to 2022, pharmaceuticals increased their share of total health expenditures in OECD countries, with 2022 the leading year and a clear upward direction over the period.
22.6 % of total health expenditures
Start
+1.49%
CAGR · 12y
27 % of total health expenditures
Projected
20102022
source-verifieddata-explorer.oecd.org2022
04 · Category
Risk & Compliance5 stats
01
1,000+ reported medical device recalls in 2022 in the U.S. (FDA recall database count)
02
24.4% increase in HIPAA breaches from 2020 to 2021 (OCR breach report trend)
03
1.2 million annual adverse events reported under Medicare in 2019 (AHRQ estimate)
04
0.5% risk of surgical complications on average in OECD countries (OECD surgical care quality indicator)
05
3.9% of hospital admissions associated with adverse drug events in a U.S. study
Interpretation
Risk & Compliance Interpretation
With over 1,000 medical device recalls in the U.S. in 2022 and a 24.4% rise in HIPAA breaches from 2020 to 2021, risk and compliance pressures are clearly intensifying alongside millions of adverse events and preventable harm signals across the care continuum.
05 · Category
Incidence And Outcomes5 stats
01
2.6 million adverse drug events occurred annually in U.S. hospitals, 2017 estimate
02
1.3% of adult hospitalizations in the U.S. resulted in a central line–associated bloodstream infection (CLABSI) in 2019 (estimate from pooled data)
03
17.7% 5-year overall survival rate for pancreatic cancer in the U.S. (SEER, all races, stages combined)
04
12.8% 5-year overall survival rate for colorectal cancer in the U.S. (SEER, all races, all stages combined)
05
8.0% 5-year overall survival rate for lung and bronchus cancer in the U.S. (SEER, all races, all stages combined)
Interpretation
Incidence And Outcomes Interpretation
Across incidence and outcomes in healthcare, the figures show a wide gap between prevention opportunities and survival realities, with 2.6 million adverse drug events annually in U.S. hospitals and 1.3% of adult hospitalizations leading to CLABSI, while long term outcomes for major cancers remain low, such as 5 year overall survival of 17.7% for pancreatic cancer and 8.0% for lung and bronchus cancer.
06 · Category
Industry Overview9 stats
01
34% relative reduction in surgical site infections with surgical antibiotic prophylaxis when administered within recommended timing (systematic review)
02
22% relative reduction in mortality with inpatient glycemic control strategies (systematic review)
03
Telehealth use in the U.S. rose from 11% of visits in 2019 to 46% in 2020 during the COVID-19 peak (private claims analysis)
04
76% of organizations reported measurable improvements in patient engagement after implementing remote patient monitoring (RPM) (industry survey)
05
9.4% of total U.S. healthcare spending was administrative costs in 2018 (IOM/other analyses compiled by Congressional Budget Office for estimation framework)
06
$1.0 trillion U.S. healthcare administrative costs estimate for 2017 (OECD/WHO compilation cited by peer-reviewed sources summarized in policy paper)
07
2.6% of total health spending in the U.S. went to research and development (OECD Health Statistics, U.S. 2021)
08
2.4x increase in use of remote patient monitoring (RPM) among health systems from 2019 to 2022 (survey-based trend)
09
71% of health systems reported using secure messaging with patients in 2023 (survey-based adoption estimate)
Interpretation
Industry Overview Interpretation
Across the industry overview, outcomes and costs are being reshaped at the same time, with evidence-based interventions cutting surgical site infections by 34% and mortality by 22% while administrative overhead remains massive at about 9.4% of U.S. healthcare spending in 2018 and $1.0 trillion in 2017.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Megan Gallagher. (2026, February 13). Medical Industry Statistics. Gitnux. https://gitnux.org/medical-industry-statistics
MLA
Megan Gallagher. "Medical Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/medical-industry-statistics.
Chicago
Megan Gallagher. 2026. "Medical Industry Statistics." Gitnux. https://gitnux.org/medical-industry-statistics.
Sources & references
45 datasets cited across this report · attribution is report-level
+13 additional datasets cited (not shown individually)